Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer’s disease
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2017.1313832
Abstract: ABSTRACT Introduction: Alzheimer disease (AD) is the most common form of dementia and its incidence is increasing at an alarming rate all over the world. The pathophysiology of AD is characterized by chronic, progressive neurodegeneration… read more here.
Keywords: phase amyloid; alzheimer disease; amyloid beta; disease ... See more keywords